期刊文献+

急性肝功能衰竭伴泌尿系和肺部感染患者的药学监护

Pharmaceutical Care for Anti-infective Therapy in A Patient with Acute Hepatic Failure Accompanied by Urinary Tract and Lung Infection
下载PDF
导出
摘要 目的:通过药师在肝功能衰竭患者伴泌尿系和肺部感染治疗过程中的药学监护,分析药师如何在临床中发挥作用。方法:以1例肝功能衰竭伴泌尿系和肺部感染患者为例,跟踪治疗全过程,并参与为其制订个体化用药方案。结果:通过临床药师参与制订用药方案,加强用药的针对性及用药过程的监护,使患者感染得到有效缓解。结论:临床药师参与肝功能衰竭患者伴泌尿系和肺部感染治疗用药会诊,体现了临床药师以患者为中心的药学服务理念,提高了救治的有效率。 Objective: To analyse pharmaceutical care for anti-infective therapy in a patient with acute hepatic failure accompanied by urinary tract and lung infection by the pharmacists, in order to investigate how the pharmacists work in the clinical practice. Methods: In case of the treatment of a patient with with acute hepatic failure accompanied by urinary tract and lung infection,clinical pharmacists took part in the whole process and formulated the individualized regimen. Results: Through the development of clinical pharmacists participating in the regimen,it strengthened the rational use of drugs and monitored the process of the treatment. Finally, the infection of the patients got effectively relieved. Conclusion: The pharmacists participated in the treatment of a patient with acute hepatic failure accompanied by urinary tract and lung infection,which manifested the pharmaceutical service with the idea of taking the patients as the center, thus improving the treatment efficiency.
出处 《抗感染药学》 2014年第5期446-450,共5页 Anti-infection Pharmacy
关键词 肝功能衰竭 临床药师 药学服务 hepatic failure clinical pharmacists pharmaceutical care
  • 相关文献

参考文献7

二级参考文献16

  • 1李肖玲,孙黎,沈金芳,陆伦根,曹爱萍,曹惠明.异甘草酸镁注射液正常人体耐受性试验[J].中国药房,2006,17(4):279-282. 被引量:20
  • 2阚家义,许威.注射用亚胺培南西司他汀钠含量和有关物质测定方法的改进[J].药物分析杂志,2006,26(3):390-392. 被引量:11
  • 3Kropp H, Sundelof JG, Kahan JS, et al. MK0787 ( N-form im idoyl thienam ycin) :evaluation of in vitro and in vitro activites[ J ]. Antim Icrob Agents Chem Other, 1980,17:993.
  • 4Mitsuhashi S. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria [ J ]. J Antimicrob Chem Other, 1983,12(Suppl D) :53.
  • 5Santos-ferreira MO, Vital JO. In - vitro antibacterial activity of imipenem compared with four other B-lactamantibiotics (ceftazidime, cefota-xime,pipera-illin and azlocillin)against 828 separate clinical isolates from a portuguese hospital [J]. J Antimierob Chem other,1986,18( Suppl E) :23.
  • 6Kropp H, Gerckens L, Sundelof JG, et al. Antibacterial activity of imipenem:the first thienamycin antibiotic[ J ]. Rev Infect Dis,1985, 7( Suppl 3) :389.
  • 7Braveny I. In vitro antibacterial activity of imipenem-a review [ J ]. EurJ Clin Microbiol, 1984,3:456.
  • 8Bund GH. Matzke GRJ[ J]. Am J Hosp Pharm,1995,4,2:129.
  • 9Kanhan FM, Kropp H, Sundelof JG, et al. Thienamycin: development of imipenem-cilastatin [ J ]. J Antim Icrob Chem Other, 1983,12 (Suppl D) : 1.
  • 10Leanza VJ, Wldonger KJ, Miller TW, et al. N-acetimidoyl and N- form imidoyl thienamycin derivatives:anti-psedomonal β-lactam antibiotics[ J ]. J Meal Chem, 1979,22 (12) : 1495.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部